Literature DB >> 2320026

A new dominant neurological mutant induced in the mouse by ethylene oxide.

S E Lewis1, L B Barnett, E C Akeson, M T Davisson.   

Abstract

This paper describes a dominant neurological mutation identified among the progeny of a male parent treated with ethylene oxide. The defects observed in the heterozygous mutant include: head tossing, poor limb coordination, and corneal clouding. Both the behavior and ocular manifestations of the mutant syndrome worsen progressively as the affected animals grow older. The mutant animals swim poorly, although they do orient themselves in reference to the surface of the water. Breeding in general is poor. Very small litter sizes result when heterozygous animals of either sex are mated to normal mice. Many male carriers are functionally sterile. All mutant animals had abnormal karyotypes. The original carrier mouse had a translocation between Chromosomes 4 and 17, which was also present in all but one mutant animal. The exceptional animal, which showed all mutant behavioral characteristics, had 41 chromosomes which included two normal 4 and 17 homologs and the small 4(17) translocation chromosome. Karyotypes of unaffected siblings of mutants were normal. Because the small translocation chromosome appears to be inseparably associated with the mutant phenotype, we have named the mutation translocation induced circling mutation symbol, Tim.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2320026     DOI: 10.1016/0027-5107(90)90088-l

Source DB:  PubMed          Journal:  Mutat Res        ISSN: 0027-5107            Impact factor:   2.433


  2 in total

Review 1.  Mouse chromosome engineering for modeling human disease.

Authors:  Louise van der Weyden; Allan Bradley
Journal:  Annu Rev Genomics Hum Genet       Date:  2006       Impact factor: 8.929

Review 2.  Genetic anomalies in mammalian germ cells and their significance for human reproductive and developmental risk.

Authors:  V L Dellarco
Journal:  Environ Health Perspect       Date:  1993-07       Impact factor: 9.031

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.